Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Cerebyx

(Fosphenytoin Injection)

0

Indications

1

Total Trials

0

Active Trials

0

Competitors

2

FDA Applications

NDA/BLA/ANDA regulatory filings

Clinical

Trials by Indication[1]

Status Epilepticus1 trial

The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus: An Open Label Clinical Trial in Dhaka Medical College Hospital

Completed·DDhaka Medical College·Approved·NCT06403150·62 enrolled

Regulatory

FDA Approval Timeline[3]

Aug 5, 1996

CEREBYX

NDA NDA020450

Nov 5, 2020

SESQUIENT

NDA NDA210864

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Fosphenytoin Injection. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fosphenytoin Injection compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA210864). U.S. Food & Drug Administration.
[4]
SEC EDGAR — Lupin Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Company: LLupin Ltd.

Related News